
Does medicine have an over-diagnosis problem?
A new book argues doctors are too quickly and too confidently diagnosing their patients with too many medical problems. Corbis via Getty Images
Patients in the 21st century are pretty lucky. Medical science and technology have advanced so much that we can diagnose many thousands of distinct conditions, and we can even take genetic tests that scour our DNA for signs of a disease that may not materialize for decades — offering us a peek into our own future.
And with these advances, we are being diagnosed more and more. The number of people diagnosed with chronic health conditions and mental health disorders is at an all-time high — at least partly, most experts agree, because we have simply catalogued more diseases to catch.
Yet we are also increasingly anxious, anxious about our health — even anxious that we're too anxious about our health. Our ability now to understand our bodies and put a name on what's wrong with them does not always provide comfort; instead, it can create new fears and impose new constraints on us. Some health care leaders, including Donald Trump's health secretary, Robert F. Kennedy Jr., argue that we are becoming over-medicalized — too ready to take a pill for something, just for the sake of taking something.
The reality is nuanced because medicine is, to put it mildly, complicated. But we should in fact be careful about doling out diagnoses, says Dr. Suzanne O'Sullivan, an Irish neurologist and the author of a new book, The Age of Diagnosis: How Our Obsession With Medical Labels Is Making Us Sicker.
In her book, O'Sullivan argues that our eagerness to diagnose, preemptively screen, and otherwise push these new tools to their limits is creating problems that deserve to be taken more seriously. She describes mutually reinforcing trends — the patient's insistence on certainty and the doctor's desire to avoid being blamed for missing something — that are driving clinical practice toward overdiagnosis. The phenomenon is even leading to more instances of doctors diagnosing certain cancers by 50 percent or more, due to the availability of new imaging tech that can detect even minuscule traces of abnormal cells.
Overdiagnosis can cause real harm. And so O'Sullivan advocates for 'slow medicine,' in which doctors and patients take time to develop a relationship, monitor symptoms, and take a great deal of care before naming a condition — an approach that may sound quaint in an era of rapid-testing but something she says is actually more in tune with the reality that diagnosis is partly an art.
'Most diagnoses come with a huge amount of uncertainty. That covers asthma, diabetes, cancer, autism. Diagnosis is a clinical skill,' she told me in a recent interview. 'Now, the difficulty, I think, with modern medicine is a lot of people don't understand that and that they feel that the test — the blood test or the brain scan — makes the diagnosis, when actually a diagnosis is made on understanding the story in the context of the tests that are done.'
There is a tension here. Slowing down could, at least in theory, risk missing an aggressive disease early at the most crucial time — when it can still be treated. And in the United States, simply getting a doctor's appointment can be more challenging than it should be.
Each individual case is unique, O'Sullivan acknowledges, which is why a relationship with your own primary care doctor is so important. But she argues that, on the whole, doctors have erred too far in the other direction, toward diagnosing conditions too quickly and too confidently and creating a different set of problems for patients. During our conversation, we spoke about how to balance our tremendous new technological abilities with a more measured approach to clinical practice and how she would respond to critics who argue her advice would lead to people's health problems being missed.
Our conversation has been edited for clarity and length.
First, let's clarify something basic. What do you mean by overdiagnosis? How do you define it?
I think of overdiagnosis as measuring the point at which a medical diagnosis ceases to be useful. A diagnosis may be right or it may be wrong, but it isn't always beneficial in a certain situation. Overdiagnosis is trying to ask when a diagnosis is genuinely a useful way of conceptualizing someone's difficulties, and when it is not.
The first chapter is about Huntington's disease. Why did you start there?
There's a genetic test available for Huntington's disease. If you happen to have the gene for Huntington's disease, you are destined to get Huntington's if you live long enough. If you have the genetic test, you can find out ahead of time that you have that at some point in your future.
I needed people to understand the power of a diagnosis to make you sick even when you actually don't have much physically wrong with you. I tell the story of a patient named Valentina, who didn't have the gene but believed that she did because of her family history. Because of her strong belief that she had the gene, she developed all the symptoms.
When we take on a medical label, when we are told that we are sick in some way, we inadvertently search ourselves for the symptoms and signs of the label that we've been given. Our bodies are very noisy engines. There's all sorts of things to notice if you are given reason to notice.
The Huntington's disease community is in this incredible situation where they have the opportunity to find out they have a diagnosis 20 years before the disease starts. And in most countries, only 10 percent to 20 percent of people actually have the genetic test that will advise them of the disease. They do that because they are a community who has given a great deal of thought to what it's like to live with the label of an impending disease.
Once you discover you have a positive test, it completely changes your relationship with your body. It changes how you think about your health. And once you know, you can't unknow. I spoke to loads of people with Huntington's, and they all said the same thing: that living with the hope that you are negative and that everything is okay is a way better life than living with the knowledge that you're positive and waiting for the disease to start.
One of the most interesting themes in the book is this idea that people want and have come to expect concrete answers from modern medicine. Black or white: You have a disease or you don't. But you cover chronic Lyme disease, long COVID, and autism, these conditions where the boundaries are fuzzier. What problems does that create?
Most diagnoses come with a huge amount of uncertainty. That covers asthma, diabetes, cancer, autism. Diagnosis is a clinical skill. It requires a good clinician to be able to put the patient's story in the context of tests and findings.
Now, the difficulty, I think, with modern medicine is a lot of people don't understand that and that they feel that the test makes the diagnosis, the blood test or the brain scan, when actually a diagnosis is made on understanding the story in the context of the tests that are done. That means that diagnosis is hugely subjective. I hear a lot of stories of people going to different doctors who said I didn't have a diagnosis, but then the 11th doctor said I did have it.
There is an inherent subjectivity that doctors will manage differently. I'm a doctor in a highly specialized center, and I deliberately err on the side of slight underdiagnosis. I do that because I'm aware that when I make a diagnosis of a brain disease, I am changing that person's future forever.
I'm not just changing their relationship with their body. I'm also changing their mortgage payments, their insurance, their confidence in themselves, their ability to get health insurance. I'm changing their finances, their practical future. I'm changing their ability to drive. There's so many things that come with the diagnosis that people don't think about.
What many, many doctors do is they err on the side of overdiagnosis because that['s an easier place for a doctor to be. Because you're never going to come back to me and say, 'Listen, I don't really believe I had asthma when I was a child.' You'll say, 'Well, listen, I had it. You treated it and now I'm better.' It protects us against someone coming back and saying we missed something.
I came into this book thinking that something like cancer would very much be more of a yes or no. You either have it or you don't. And if you do, you really would want to know about it — as soon as possible.
And yet, after reading your book, I felt like you had complicated that story. How do we risk overdiagnosing cancer?
Within the medical community, this has been well-known for a long time, but it just doesn't leak into the general conversation. The bottom line is if you screen healthy people for an illness, any illness, be it cancer or high blood pressure, diabetes, then you will be picking up borderline cases and overtreating them.
In the case of cancer, I try to remind people we've only had MRI scans in regular clinical use in doctors' offices since the 1990s. They've only been as good as they are now in the last 10 years, as sensitive at picking up things. As we get these newer tests, we're finally seeing inside the healthy body of people.
What we find when we screen people for things like cancer is we find abnormal cells. But not all abnormal cells go into cancer. Lots of people live out their lives having these abnormal cells. They never spread. They never do anything. They never grow. They would never threaten health. But our difficulty as doctors is because we're so new to finding all these irregular abnormalities that when we find them, we don't know which ones will turn into malignant cancers and which ones won't.
So what we do is we treat them all as if they will inevitably turn into malignant cancers. One Cochrane Review estimated that if you screen 2,000 women for breast cancer, you will save one woman's life from breast cancer and treat 10 women for breast cancer who never needed to be treated.
I think sometimes we're very in love with all of our access to screening tests and scans and health checks. A lot of that care is not only unnecessary, but actually doing us harm.
One estimated that if you screen 2,000 women for breast cancer, you will save one woman's life from breast cancer and treat 10 women for breast cancer who never needed to be treated.
Obviously being able to better more precisely diagnose conditions and to test samples at a genetic level represents advancement in science and an improvement in our understanding of our own body. How do we encourage that kind of development while mitigating the problems that you're writing about?
I work with people who've got rare brain diseases. The advancement in genetics and the ability to diagnose rare genetic conditions is amazing. I don't want to in any way detract from what a phenomenal kind of medical advancement that is. I have no doubt that going forward in 20, 30, 40 years, it will continue contributing to science and to medicine in very positive ways.
How to talk to your doctor about 'slow' medicine
O'Sullivan's book is not a self-help guide, but after reading it, it's easy to come up with some strategies that could help each of us bring a 'slow-medicine' sensibility to our next doctor's appointment and potentially avoid overdiagnosis. Such as:
• Set expectations with your doctor. Make clear that you don't want to be quick to judgment or treatment.
• Press your doctor to get a better sense of how confident they are in a diagnosis, what could change their mind, what additional steps could be taken to double-check.
• If you're really worried about something, speak up. Slow medicine means being thoughtful — not ignoring what your body is telling you.
But something being modern and expensive and cutting-edge doesn't mean it's always better medicine. We need to be a little bit more open with the general public about the uncertainties.
We'll never understand the meaning of different genes to healthy populations if we don't test them, so we need to do the population-based testing. But we need to be careful before we begin offering genetic tests to unsuspecting members of the public who probably think we understand them a great deal better than we do.
We're really on a learning curve at the moment. A little bit more clarity and honesty with the public would go a long way.
How would you respond to somebody who hears we should be testing less and diagnosing less and immediately thinks, 'Well, you're just going to put my health at risk.'
Listen, I don't want a diagnosis missed in myself. I don't want to be the doctor who misses things either. So I completely understand people's fear of dialing back.
It's not about replacing all these tests with nothing. It's really advocating for this concept of slow, thoughtful medicine with good clinicians that we invest in good doctors, good nurses, good diagnosticians, and we don't feel the need to be compelled to jump into tests and diagnosis at that first meeting. We have time to spend with our patients and meet them again to discuss the problem. That's how you come to both a good understanding between patient and doctor. A quality diagnosis is made with time and understanding.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
2 days ago
- Newsweek
FDA Issues Highest Risk Warning For Mushroom Recall
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A recall of mushrooms over food poisoning contamination fears has been classified with the highest possible health risk after experts ruled consuming the products could prove fatal. The new assessment of the threat posed by the mushrooms on Friday follows the initial recall of the product in June, amid concern that the fungi could contain the food poisoning bug listeria. Mushrooms under the brand names Peeters Mushroom Farm and Aunt Midi's Fresh Sliced Mushrooms, which were both distributed by Canadian firm Wiet Peeters Farm Products Limited, were recalled on June 29. On Friday (July 18), the Food and Drug Administration (FDA) classified the recall as a Class I health hazard. Newsweek has reached out by email outside of regular working hours to Wiet Peeters Farm Products Limited, based in Charing Cross in Ontario, seeking further information and comment. Mushroom are cultivated at a farm in this archive stock image taken in September 2018 in Rwanda. Mushroom are cultivated at a farm in this archive stock image taken in September 2018 in Rwanda. Camille Delbos/Art In All of Us/Corbis via Getty Images Why It Matters The recall affects consumers across Michigan and Ohio after the mushrooms were distributed throughout the states. More than 200 cases of the fungi were recalled after they had been shipped out to retailers. The recall of the mushrooms was initiated over fears they had the "potential to be contaminated with Listeria monocytogenes," according to documents published online by the Food and Drug Administration (FDA). Listeria is a bacteria that can cause severe food poisoning if consumed. Symptoms, which can last for hours or days, most typically include diarrhea, stomach cramps, vomiting, and fever. It can make people fall sick within a few hours or after a few days, the Centers for Disease Control and Prevention says, and can be deadly in the most severe cases. What To Know The mushrooms affected by the recall are: Peeters Mushroom Farm Cremini Sliced mushrooms 227g (8 oz.) UPC 0 68414 96960 3 on the flat black plastic package and the best before indicator "25JL04" stamped on the side. (25 cases distributed, 12 packages per case). 227g (8 oz.) UPC 0 68414 96960 3 on the flat black plastic package and the best before indicator "25JL04" stamped on the side. (25 cases distributed, 12 packages per case). Peeters Mushroom Farm Thick Slice Mushroom 10 lb cardboard container labeled with Peeters Mushroom Farm. (10 cases distributed) 10 lb cardboard container labeled with Peeters Mushroom Farm. (10 cases distributed) Aunt Mid's Fresh Sliced Mushrooms 227g (8 oz.) UPC 0 33383 676005 on the packaging, with a best before (or "meilleur avant") indicator "25JL04" on the side. (175 cases distributed) Although the best before dates passed earlier this month, it's possible the mushrooms may have been cooked and frozen by consumers. "No illnesses have been reported to date in connection with this problem," the company said in a press release on July 10. The potential for contamination was discovered after testing by the Canadian Food Inspection Agency revealed the presence of listeria in some mushrooms. The FDA has now classified the recall as a "Class I" health risk, the most severe warning, encompassing the potential for serious health consequences or death. There are three classes in total, with Class II meaning that temporary or reversible health consequences are possible although remote, and Class III meaning the affected product is not likely to cause health problems. It is not the first time that potentially deadly mushrooms have hit the news. Enoki mushrooms distributed by a New York company were also recalled nationwide amid fears they could also contain listeria earlier this month. Australian mum Erin Patterson was recently convicted of killing her estranged husband's relatives with a poisoned mushroom lunch. She is awaiting sentencing after jurors found her guilty of deliberately lacing her in-laws' beef wellingtons with toxic death cap mushrooms. What People Are Saying Wiet Peeters Farm Products Limited said in a press release that the mushrooms were being recalled "because they have the potential to be contaminated with Listeria monocytogenes." The firm added: "Listeria monocytogenes is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women." What Happens Next Consumers who purchased the mushrooms "are urged to return them to the place of purchase for a full refund," the company said. Consumers with questions should contact Wiet Peeters Farm Products Limited on 1-519-351-1945 or Toll Free 1-800-364-1305 between 7:00 a.m. to 3:30 p.m. EST. Monday to Friday.


Vox
4 days ago
- Vox
The brain tech revolution is here — and it isn't all Black Mirror
is a senior editorial director at Vox overseeing the climate teams and the Unexplainable and The Gray Area podcasts. He is also the editor of Vox's Future Perfect section and writes the Good News newsletter. He worked at Time magazine for 15 years as a foreign correspondent in Asia, a climate writer, and an international editor, and he wrote a book on existential risk. When you hear the word 'neurotechnology,' you may picture Black Mirror headsets prying open the last private place we have — our own skulls — or the cyber-samurai of William Gibson's Neuromancer. That dread is natural, but it can blind us to the real potential being realized in neurotech to address the long intractable medical challenges found in our brains. In just the past 18 months, brain tech has cleared three hurdles at once: smarter algorithms, shrunken hardware, and — most important — proof that people can feel the difference in their bodies and their moods. A pacemaker for the brain Keith Krehbiel has battled Parkinson's disease for nearly a quarter-century. By 2020, as Nature recently reported, the tremors were winning — until neurosurgeons slipped Medtronic's Percept device into his head. Unlike older deep-brain stimulators that carpet-bomb movement control regions in the brain with steady current, the Percept listens first. It hunts the beta-wave 'bursts' in the brain that mark a Parkinson's flare and then fires back millisecond by millisecond, an adaptive approach that mimics the way a cardiac pacemaker paces an arrhythmic heart. In the ADAPT-PD study, patients like Krehbiel moved more smoothly, took fewer pills, and overwhelmingly preferred the adaptive mode to the regular one. Regulators on both sides of the Atlantic agreed: The system now has US and EU clearance. Because the electrodes spark only when symptoms do, total energy use is reduced, increasing battery life and delaying the next skull-opening surgery. Better yet, because every Percept shipped since 2020 already has the sensing chip, the adaptive mode can be activated with a simple firmware push, the way you'd update your iPhone. Waking quiet muscles Scientists applied the same listen-then-zap logic farther down the spinal cord this year. In a Nature Medicine pilot, researchers in Pittsburgh laid two slender electrode strips over the sensory roots of the lumbar spine in three adults with spinal muscular atrophy. Gentle pulses 'reawakened' half-dormant motor neurons: Every participant walked farther, tired less, and — astonishingly — one person strode from home to the lab without resting. Half a world away, surgeons at Nankai University threaded a 50-micron-thick 'stent-electrode' through a patient's jugular vein, fanned it against the motor cortex, and paired it with a sleeve that twitched his arm muscles. No craniotomy, no ICU — just a quick catheter procedure that let a stroke survivor lift objects and move a cursor. High-tech rehab is inching toward outpatient care. Mental-health care on your couch The brain isn't only wires and muscles; mood lives there, too. In March, the Food and Drug Administration tagged a visor-like headset from Pulvinar Neuro as a Breakthrough Device for major-depressive disorder. The unit drips alternating and direct currents while an onboard algorithm reads brain rhythms on the fly, and clinicians can tweak the recipe over the cloud. The technology offers a ray of hope for patients whose depression has resisted conventional treatments like drugs. Thought cursors and synthetic voices Cochlear implants for people with hearing loss once sounded like sci-fi; today more than 1 million people hear through them. That proof-of-scale has emboldened a new wave of brain-computer interfaces, including from Elon Musk's startup Neuralink. The company's first user, 30-year-old quadriplegic Noland Arbaugh, told Wired last year he now 'multitasks constantly' with a thought-controlled cursor, clawing back some of the independence lost to a 2016 spinal-cord injury. Neuralink isn't as far along as Musk often claims — Arbaugh's device experienced some problems, with some threads detaching from the brain — but the promise is there. On the speech front, new systems are decoding neural signals into text on a computer screen, or even synthesized voice. In 2023 researchers from Stanford and the University of California San Francisco installed brain implants in two women who had lost the ability to speak, and managing to hit decoding times of 62 and 78 words per minute, far faster than previous brain tech interfaces. That's still much slower than the 160 words per minute of natural English speech, but more recent advances are getting closer to that rate. Guardrails for gray matter Yes, neurotech has a shadow. Brain signals could reveal a person's mood, maybe even a voting preference. Europe's new AI Act now treats 'neuro-biometric categorization' — technologies that can classify individuals by biometric information, including brain data — as high-risk, demanding transparency and opt-outs, while the US BRAIN Initiative 2.0 is paying for open-source toolkits so anyone can pop the hood on the algorithms. And remember the other risk: doing nothing. Refusing a proven therapy because it feels futuristic is a little like turning down antibiotics in 1925 because a drug that came from mold seemed weird. Twentieth-century medicine tamed the chemistry of the body; 21st-century medicine is learning to tune the electrical symphony inside the skull. When it works, neurotech acts less like a hammer than a tuning fork — nudging each section back on pitch, then stepping aside so the music can play. Real patients are walking farther, talking faster, and, in some cases, simply feeling like themselves again. The challenge now is to keep our fears proportional to the risks — and our imaginations wide enough to see the gains already in hand. A version of this story originally appeared in the Good News newsletter. Sign up here!


Vox
5 days ago
- Vox
Your health insurance premiums could soon go up 15 percent — or more
covers health for Vox, guiding readers through the emerging opportunities and challenges in improving our health. He has reported on health policy for more than 10 years, writing for Governing magazine, Talking Points Memo, and STAT before joining Vox in 2017. We just got a preview of the likely consequences of the 'big, beautiful bill' passed by Republicans in Congress and signed by President Donald Trump: Premiums on the Affordable Care Act's health insurance marketplaces are on track to increase 15 percent on average next year — a record-setting pace. This comes from a new analysis of more than 100 health insurers selling plans to individuals on the ACA marketplaces that additionally found that plan premiums increases are twice that in 2025 and the highest single-year increase since 2018. According to the experts from KFF, a health policy think tank, one out of every four plans is raising its rates by 20 percent or more. Peterson-KFF Health System Tracker These rates are preliminary and will be finalized later this summer. Though the new rates were actually filed before the Republican 'big, beautiful bill' passed in Congress earlier this month, KFF experts explain that the GOP's agenda is playing a role in these cost increases — and it may drive prices up even more in the future. Here's what all of this means for you: If you buy insurance on your own through the ACA's marketplaces, your coverage may be a lot more expensive as soon as you sign up for coverage next year. If you're on Medicaid, the GOP's bill creates new work requirements that will take effect next year and could put your benefits at risk. And if you get insurance through your employer, your premiums are going to grow too if other people lose coverage, which is more likely to happen because of all of these changes. Let's break it down. Why all of this is happening, briefly explained As Republicans were pulling together their budget bill, there was the clear question of what to do about enhanced ACA subsidies that have been in place since 2021, first authorized by the Democrats as part of their own budget reconciliation legislation. At the time, the enhanced subsidies both lowered costs for people already eligible for financial aid under the law and extended eligibility for financial assistance for the first time to more middle-class families. Marketplace enrollment nearly doubled from 2021 to 21 million in 2024 as a result. But the enhanced subsidies were only authorized through 2025. Republicans, who had previously criticized the ACA for making health insurance unaffordable for the middle-class people who have now gained coverage through the expanded assistance, opted not to include an extension of the subsidies as part of their tax-and-spending bill. Instead, they chose to allow the subsidies to lapse, while slashing Medicaid spending over the next decade and providing an outsized tax cut for businesses and the wealthy. It is possible that these subsidies could be saved if Democrats and some Republican lawmakers can band together to craft a bipartisan deal to maintain the subsidies later this year, but DC insiders are dubious that one can be struck. If the subsidies do indeed end, they add more pain to the other regulatory changes that are coming to limit financial aid on the marketplaces. These combine to an estimated 5.1 million people who could become uninsured. These consequences will have ripple effects: The people who drop coverage are projected to be healthier, because they are more likely to think they could live without health coverage, which leaves a sicker and costlier pool of patients in the marketplace. Insurers are already pricing that shift in. According to the KFF analysis, health plans are citing the lapsed subsidies to explain the proposed rate increases, with the policy change contributing about 4 percent to the rate hike on average. The threat of tariffs from Trump has been cited for another 3 percent increase by some plans. The rest of the proposed rate hikes are attributed to the continued growth in the prices for medical services, which has been ongoing for decades. And these increases may be only the beginning. The Republican bill's changes to Medicaid don't take effect until the end of 2026, but they could also push premiums higher if millions of people lose coverage as expected. When people lose Medicaid, they are more likely to end up in the emergency room. That requires more costly care than they'd get if they were insured. Those increased costs to hospitals are passed on to insured patients when providers negotiate their payment rates with health insurance plans. Whether patients will blame the GOP for these cost increases remains to be seen. But their wallets are already feeling the effects of the Republican budget bill.